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ABSTRACT  45 
Background - There is a limited evidence on how active commuting is associated with 46 
health benefits in developing countries. The aim of this study therefore was to 47 
investigate the associations between active commuting and makers of adiposity and 48 
cardiometabolic risk in the Chilean adult population 49 
Methods - 5,157 participants from the Chilean National Health Survey 2009-2010 were 50 
included in this cross-sectional study. Active commuting was measured using the 51 
Global Physical Activity Questionnaire (GPAQ v2). Body mass index (BMI) and waist 52 
circumference (WC) were measured and used to define obesity and central obesity. 53 
Type 2 diabetes (T2D) and metabolic syndrome was determined using WHO and update 54 
ATPIII-NCEP criteria, respectively. . 55 
Results - The main finding of this study revealed that 30 minutes increase in active 56 
commuting was associated with lower odds for BMI >25.0kg.m-2 (0.93 [95% CI: 0.88 a 57 
0.98, p=0.010]). Similarly the odds for central obesity was 0.87 [0.82 a 0.92, p<0.0001]. 58 
Similar associations were found for T2D (0.81 [0.75 to 0.88]) and metabolic syndrome 59 
(OR: 0.86 [0.80 to 0.92]). 60 
Conclusion - Our findings shown that active commuting is associated with a lower 61 
adiposity and a healthier metabolic profile including lower risk for obesity, diabetes and 62 
metabolic syndrome.  63 
Keywords – active commuting; obesity; diabetes, metabolic syndrome    64 
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INTRODUCTION 65 
Despite the known protective effects of increased physical activity (PA) against 66 
morbidity and mortality, approximately one third of the world’s population remains 67 
physically inactive (1, 2). Recently, physical inactivity was cited as the fourth leading 68 
cause of non-communicable disease (NCD) mortality, attributable for 5.3 million deaths 69 
per year (3). Global trends, however, indicate prevalence of physical inactivity 70 
continues to increase, particularly among low and middle income countries (2).  71 
 72 
In southern Latin American countries, sustained periods of economic growth 73 
accompanied by rapid urbanisation of previously rural populations have resulted in 74 
paradigm shifts in lifestyle behaviours (4, 5). Increased access to household appliances, 75 
televisions, and motorised transportation has been paralleled by decreases in overall 76 
levels of PA and increased sedentary behaviour (5). Subsequently, burden of NCDs has 77 
increased in this region, and cardiovascular disease has been the leading cause of 78 
mortality over the last two decades (6).  79 
 80 
Declines in active commuting are suggested to be at least partially responsible for 81 
overall declines in population PA, as urban population growth has outpaced 82 
infrastructure development and people have shifted to more personalised modes of 83 
motorised transport (i.e. driving cars) (7). In 1960 a 60% of the total population in Chile 84 
use to live in urban setting, however in 2015 more than 90% is currently living in urban 85 
cities (8). This growth in urbanization has been more rapidly than in some major 86 
developed countries such as United States and United Kingdom, which increased 87 
urbanization approximately from 78% to 83% during these years (8). Along with this 88 
changes the numbers of cars in Chile has increased from 2 million in 1998 to more than 89 
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4.6 million in 2015, while the number of bicycles have increased from 1.1 million to 1.9 90 
million (9).   91 
Active commuting is recommended as a simple way of increasing PA, and recent 92 
research has continually reported the health benefits (10). Investigations into the effects 93 
of active commuting on markers of adiposity and cardiometabolic health have reported  94 
improved cardiovascular risk profiles and lower prevalence of obesity in whose who 95 
actively commute (11-14). A recent study (n>250,000) reported that active commuters 96 
(cycling and walking) is associated with reduce risk of all-cause mortality, CVD and 97 
cancer incidence and mortality (10).  98 
 99 
Population level observations of active commuting trends are predominantly available 100 
in high income countries (2), and any observed associations may not be generalizable to 101 
other regions. While there is limited evidence of the effects of active commuting in low 102 
to middle-income countries (15, 16), associations between active commuting and 103 
prospective health outcomes in southern Latin American countries remain largely 104 
unestablished. The aim of this study was therefore to investigate the associations 105 
between active commuting and markers of adiposity and cardiometabolic risk in the 106 
Chilean adult population. 107 
 108 
METHODS 109 
Study Population 110 
This cross-sectional study was based on data from participants aged ≥15 years from the 111 
2009-2010 Chilean National Health Survey (CNHS). The CNHS is a large, nationally 112 
representative population-based study of risk factors, dietary status and health 113 
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conducted every 6 years in Chile. Complex random stratified sampling was used to 114 
cover a nationally representative sample based on statistics from the 2002 Chilean 115 
National Census, which included strata from administrative regions (county) and 116 
urban/rural locations, as described in detail elsewhere . 117 
 118 
Response rate from the eligible population to the CNHS was 85%. A total 5,276 (97%) 119 
provided data on PA behaviours collected with the Global Physical Activity 120 
Questionnaire (GPAQ), version 2. Participants aged <18 years (n=224) were excluded 121 
from the current analysis (results will be reported elsewhere). In addition, 121 122 
participants (3%) with PA data were excluded based on the GPAQ protocol for outlier 123 
detection (48% women). Complete data was available for 5,155 participants for the 124 
present analysis (17). 125 
 126 
Measurements 127 
Socio-demographics 128 
To ensure quality of data collection, standardised protocols were used and nurses and 129 
technicians underwent joint training sessions prior to the survey (17). Socio-130 
demographic data was collected for all participants, including age, gender, education 131 
level (primary or <8 years, secondary or between 8-12 years, and beyond secondary or 132 
>12 years of schooling), and smoking status (non-smoker, ex-smoker or smoker). 133 
Dietary intake was measured using a dietary intake  questionnaire, which include 134 
questions regarding frequency and quantity of consumption of fruit and vegetables, 135 
alcohol and salt intake. 136 
 137 
Anthropometrics  138 
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Height was measured to the nearest 0.1 cm using a portable stadiometer and weight was 139 
measured to the nearest 0.1 kg using a digital scale (Tanita HD313) with participants 140 
removing their shoes and wearing light clothing. Body mass index was calculated as 141 
[weight/height2] and classified using the World Health Organization (WHO) criteria 142 
(<18.5 kg.m-2 – underweight, 18.5 to 24.9 kg.m-2 – normal, 25.0 to 29.9 kg.m-2 – 143 
overweight and ≥30 kg.m-2 – obese) (18). Central obesity was defined using waist 144 
circumference (>88cm for women and >102cm for men).  145 
 146 
Metabolic outcomes 147 
Fasting glucose and haemoglobin A1c (HbA1c) were measured from whole blood 148 
collected by trained nurses after an eight hour overnight fast. Analysis of samples was 149 
conducted in a certified laboratory facility and has been described in detail elsewhere 150 
(17) . T2D was determined via the WHO criteria (fasting plasma glucose ≥ 126mg.dl-1) 151 
(19) and/or by self-report of a pre-existing medical diagnosis and/or in those who 152 
reported using glucose lowering medication. Metabolic syndrome was determine 153 
according to the National Cholesterol Education Program Adult Treatment Panel III 154 
(NCEP ATP III) as the presence of 3 or more of the following: waist >102 cm in men, 155 
>88 cm in women; triglycerides ≥ 1.70 mmol/l (150 mg/dL); high density lipoprotein 156 
cholesterol (HDL-C) <1.03 mmol/l (40 mg/dL) in men, <1.29 mmol/l (50 mg/dL) in 157 
women; blood pressure ≥ 130/85 mm Hg; and fasting plasma glucose ≥ 6.11 mmol/l 158 
(110 mg/dL) or self-reported diabetes (20).   159 
 160 
Physical activity 161 
The GPAQ (version 2) was used to measure PA and sedentary behaviour in the CNHS. 162 
Developed by the WHO to measure population-level PA behaviours, the GPAQ uses 163 
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standardised protocols shown to be valid and reliable and adaptable to incorporate 164 
cultural and other differences (21, 22). The GPAQ assesses sedentary behaviour (total 165 
time spent sitting) and time spent on active-commuting (PA from travel). For active 166 
commuting domain participants were ask the following question a) Do you walk or use 167 
a bicycle (pedal cycle) for at least 10 minutes continuously to get to and from places? 168 
(Yes, No); b) In a typical week, on how many days do you walk or bicycle for at least 169 
10 minutes continuously to get to and from places?; and c) How much time do you 170 
spend walking or bicycling for travel on a typical day?.  These questions were used to 171 
derive time spent on active commuting in minutes per day. Total PA was reported as 172 
metabolic-equivalent value (MET) using recommendations made by the GPAQ protocol 173 
(4-METs was used for transport-related activities and moderate intensity physical 174 
activities, whereas 8-METs was used for Vigorous intensity physical activities) (23). 175 
The GPAQ uses algorithms to categorize weekly PA into two categories: inactive 176 
individuals (<600 MET.min.week-1) and active individuals (≥600 MET.min.week-1) 177 
(23). Sedentary behaviour was derived using the following question: How much time do 178 
you usually spend sitting or reclining on a typical day? (23). 179 
 180 
Statistical Analysis 181 
Survey-weighted descriptive characteristics are presented as adjusted means with 182 
standard deviation (SD) for quantitative variables or as a proportion for categorical 183 
variables. Quantitative data was checked for normality using skewness and kurtosis 184 
normality tests. For statistical analysis, active commuting was stratified into 4 185 
categories based on self-reported time spent on active commuting (0: participants who 186 
reported not doing active commuting; >30 minutes a day; 30 to 60 minutes a day and 187 
>60 minutes a day).  188 
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To investigate the association of active commuting with adiposity and metabolic 189 
markers, linear regression analysis were performed. Active commuting was fitted into 190 
the model as an ordinal variable variable (0= non-active commuters, 1= >30; 2= 30 to 191 
60, and 3= >60 minutes a day). The association of active commuting categories with 192 
obesity, central obesity, T2D and metabolic syndrome were investigated using logistic 193 
regression analyses. All models were adjusted for age, sex, education, smoking, leisure 194 
PA, sitting time, fruit and vegetable, salt and alcohol intake. Metabolic markers were 195 
additionally adjusted for BMI.  196 
To account for the differential probability of selection, all outcome estimates (deltas and 197 
odds ratio) were weighted using the sample weights provided by CNHS(17). Statistical 198 
analyses were conducted using STATA 14 (StataCorp; College Station, TX). A two-199 
sided α-level of 0.05 was used and all analyses accounted for the complex sample 200 
design of CNHS data. 201 
 202 
RESULTS 203 
The main characteristics of the participants by active commuting are summarised in Table 204 
1. In summary, individuals who actively commuted were more likely to have high levels 205 
of education and household income, and had a slightly higher prevalence of smokers and 206 
had a lower prevalence of obesity and physical inactivity compared to the non-active 207 
commuting group. Active commuters had a lower BMI and waist circumference, and had 208 
higher levels of total physical activity in comparison to those reporting no active 209 
commuting (Table 1). No major differences were found on time spent on sedentary 210 
behaviour and dietary intake patterns between active and non-active commuters.  211 
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Overall, there was a significant association of active commuting time with obesity and 212 
metabolic markers (Figure 2). Body mass index and WC were -0.56 kg.m-2 and -01.12 213 
cm lower in individuals who accumulate between 1-30 minutes of active commuting per 214 
day compare to non-active commuters. Larger differences were observed on WC for those 215 
who accumulate between 30-60 or >60 minutes.week-1 (-1.90 and -2.23 cm, respectively) 216 
but not for BMI (-0.63 and -0.62 kg.m-2, respectively) compare to non-active commuters. 217 
. Fasting glucose concentration were significantly lower on those achieving 30-60 and 218 
>60 min.day-1 compare to non-active commuters (-0.12 and -0.22 mmol.l-1, respectively). 219 
No significant differences were found for those accumulating <30 min.day-1compare to 220 
non-active commuters (-0.09 mmol.l-1). Whereas, systolic blood pressure compare to non-221 
active commuters was significantly lower in those accumulating <30, 30-60 and >60 222 
min.day-1 (-2.3, -2.72 and -3.8 mmHg, respectively). No differences were found for total 223 
cholesterol, HDL cholesterol, triglycerides and diastolic blood pressure between active 224 
commuting groups (Fig 1).   These associations were independent of socio-demographics, 225 
smoking, sedentary behaviour, dietary behaviour and BMI (when glucose was used as 226 
main outcome). However, no association were found for active commuting and lipids 227 
profile (total cholesterol, HDL-cholesterol and triglycerides) and diastolic blood pressure 228 
(Fig 1).  229 
When the association of active commuting time with obesity, T2D and metabolic 230 
syndrome was investigated we found a significant trend to reduce the odds for all these 231 
risk factors with increasing active commuting time in comparison to those who report not 232 
doing active commuting (Figure 2). The odds for overall obesity (BMI >30.0 kg.m-2) was 233 
25%, 26% and 33% lower on those who accumulate <30, 30-60 and >60 min.day-1 234 
compare to non-active commuters. Similar results were found for central obesity (20%, 235 
21% and 31),  but higher reduction in the odds were found for T2D (26%, 27% and 48%)) 236 
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and metabolic syndrome (33%, 34% and 63%) for those who accumulate <30, 30-60 and 237 
>60 min.day-1, respectively, compare to those who did not reporting any active 238 
commuting. These results were independent of socio-demographics, smoking, sedentary 239 
behaviour, dietary behaviour and BMI (this last one was added when T2D and metabolic 240 
syndrome were used as outcomes) (Figure 2).  No significant differences were found 241 
between active commuting groups (<30, 30-60 and >60 min.day-1) for any of the health 242 
outcomes (P>0.05).  243 
 244 
DISCUSSION  245 
Main finding of this study 246 
The main findings of this study were that active commuting was significantly associated 247 
with markers of adiposity and metabolic disease, and incidence of obesity, T2D and 248 
metabolic syndrome. The higher the time spent on active commuting the larger were the 249 
benefits for T2D, waist circumference and systolic blood pressure. Our results revealed 250 
that these associations were independent of age, sex, education, leisure time PA, 251 
sedentary behaviour, dietary intakes and BMI (when adiposity markers were not the 252 
outcome). As active commuting has been reported to contribute to overall PA (24, 25), 253 
these results may have important public health implications. Improved provisions for 254 
active commuting may facilitate population level health benefits, as it is an inexpensive 255 
mode of increasing PA. 256 
 257 
What is already known on this topic 258 
The extensive evidence of associations with health for both overall and leisure-time 259 
physical activity (26, 27) contrasts with limited evidence of the effects of non-leisure time 260 
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physical activity, such as active commuting, on prospective health outcomes. Previous 261 
observational studies have reported similar findings to our own in that active commuting 262 
may be associated with lower adiposity and reduced likelihood of obesity (11, 12, 14). A 263 
large cross sectional analysis of ~150,000 people from the UK Biobank cohort reported 264 
that mixed-mode commuters (i.e. public transport and active commuters)(men: β 265 
coefficient -1.00 kg.m2 [95% CI: -1.14 to -0.87], p<0.0001; women: -0.67 kg.m2 [-0.86 266 
to -0.47], p<0.0001) had favourable adiposity profiles compared to car-only commuters, 267 
however the greatest protective benefits of active commuting were observed in those who 268 
reported some cycling during their commute (i.e. cycling or walking and cycling)(men: β 269 
coefficient -1.71 kg.m2 [95% CI: -1.86 to -1.56], p<0.0001; women: -1.65 kg.m2 [-1.92 270 
to -1.38], p<0.0001) (11). Our data was limited to stratify the analysis by type of active 271 
commuting (walking or cycling), as the questionnaire used to collect such information 272 
does not include separate question for cycling and walking. However our study provides 273 
some evidence that even relatively low levels of active commuting (<30 mins.day-1) may 274 
be beneficial for markers of adiposity, compared to people who do not actively commute.  275 
 276 
The association between active commuting and incidence of T2D has been previously 277 
reported, but remains equivocal. In Finnish adults, >30 mins per day active commuting 278 
(defined as walking or cycling) reduced risk of T2D by 36% (HR: 0.64 [0.45 to 0.92]) 279 
compared to non-active commuters; and >21 minutes of walking to work per day reduced 280 
the likelihood of T2D in Japanese men by 27% (OR: 0.73 [0.58 to 0.92])(28, 29). Despite 281 
this, another study of Japanese men reported that walking to work was not associated with 282 
incidence of T2D, regardless of how many mins.day-1 were reported (13). Our data 283 
provides novel evidence of the associations between active commuting and prevalent 284 
T2D in a Latin American cohort, and suggests that even low levels of active commuting 285 
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may be protective against T2D and metabolic syndrome in this population. Other studies 286 
conducted in low to middle-income countries (China, India, Mexico, Ghana, Russia and 287 
South Africa) (15, 16), have reported that use of active travel for ≥150 min per week is 288 
more common in lower socio-economic groups and appears to confer similar health 289 
benefits (lower BMI and systolic blood pressure) to those identified in high-income 290 
settings (15, 16). 291 
Interestingly, we did not found an association of active commuting with HDL-cholesterol 292 
and diastolic blood pressure, which is in disagreement with a previous study were active 293 
commuters have shown favourable metabolic health compare to non-active commuters 294 
(14). However, a study conducted in Chinese population found no association between 295 
active commuting time and diastolic blood pressure or HDL-cholesterol in men  although 296 
the association was significant for women (30, 31). Up to date, there are limited numbers 297 
of studies, which have reported the metabolic benefits of active commuting, most of them 298 
up to date have focus on obesity and mortality outcomes (10, 29, 32-36). Due to our study 299 
did not collected information about the intensity or type of the active commuting; we 300 
cannot discard a potential confounding effect of these variables.  Moreover, our analysis 301 
were not stratified by sex, therefore we do not know whether the lack of association could 302 
by driven my men, as previous studies have reported. However, our analysis did not found 303 
a significant commuting*sex interaction, so no major differences should be expected 304 
within sex.  305 
 306 
What this study adds 307 
Data from the 2010 Chilean National Health Survey showed that >60% of the population 308 
participated in some form of active commuting. Active commuting may have important 309 
contributions to overall PA in this cohort, as 100% of those who reported >30 mins.day-310 
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1 of active commuting were meeting the physical activity guidelines. This was compared 311 
to only 47.8% of those who reported no active commuting.  Policies and infrastructure 312 
designed to increase population level active commuting presents major opportunities for 313 
preventive public health measures in terms of obesity and cardiometabolic risk. 314 
 315 
Limitations of this study 316 
The CNHS offer an opportunity to test our research question in a nationally representative 317 
sample of the adult Chilean population. Moreover, the inclusion of a wide range of health, 318 
demographic and behavioural variables in the dataset allowed for comprehensive 319 
adjustment for the effect of confounding factors. However, a key limitation of this study, 320 
in common with much of the literature on active commuting and health, is the somewhat 321 
crudely quantified exposure. The CNHS participants were asked to give their time spent 322 
on transport-related physical activity, meaning mixed-mode journeys were not captured. 323 
It is therefore likely that the people who reported using a form of public transport as their 324 
main mode were highly heterogeneous in terms of the levels of physical activity their 325 
commutes entailed. The cross-sectional nature of this study provides further limitation. 326 
As is the case with any observational study, there is the possibility of reverse causation 327 
and residual confounding. While we have attempted to minimise residual confounding 328 
through adjustment for multiple confounding lifestyle factors, our results do not imply a 329 
causative relationship, and further well controlled studies are required to investigate this. 330 
 331 
In conclusion, the present data shows a clear association between active commuting and 332 
lower adiposity and odds for cardiovascular risk factors, independent of major potential 333 
confounding factors. Thus, interventions to increase active commuting could be 334 
15 
 
considered as part of strategies to increase physical activity levels in the population and 335 
therefore reduce the population burden of cardiometabolic disorders.   336 
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Table 1. Cohort characteristic by active commuting categories. 446 
 Active commuting (min.day-1) 
 None  <30 30-60 >60 
Socio-demographics      
n 1794 1469 770 1260 
Women, n (%) 1.110 (61.8) 896 (60.9) 446 (57.9) 691 (54.8) 
Age (years) mean (SD) 49.4 (19.3) 45.7 (18.9) 44.8 (17.) 43.7 (17.6) 
Education, n (%) 
< 8 years 
8 to 12 years 
>12 years 
 
547 (30.6) 
956 (53.5) 
284 (15.9) 
 
393 (26.9) 
760 (52.1) 
304 (20.9) 
 
175 (22.7) 
442 (57.4) 
153 (19.9) 
 
293 (23.3) 
725 (57.6) 
241 (19.1) 
Anthropometric     
Weight (kg), mean (SD) 72.2 (14.8) 71.1 (14.9) 71.4 (14.9) 71.8 (14.6) 
BMI (kg.m-2), mean (SD) 28.2 (5.3) 27.6 (5.3) 27.6 (5.5) 27.6 (5.3) 
BMI categories, n (%) 
<18.5 kg.m-2 
18.5–24.9 kg.m-2 
25.0–29.9 kg.m-2 
≥30.0 kg.m-2 
 
22 (1.4) 
430 (26.6) 
636 (39.3) 
529 (32.7) 
 
20 (1.5) 
402 (30.0) 
551 (41.1) 
369 (27.5) 
 
13 (1.9) 
213 (30.8) 
287 (41.5) 
179 (25.9) 
 
26 (2.3) 
347 (30.1) 
455 (39.5) 
325 (28.2) 
Waist circumference (cm), mean 
(SD) 
97.4 (12.8) 96.3 (12.7) 95.5 (11.9) 95.2 (12.1) 
Central obesity, n (%) 1211 (74.0) 935 (69.4) 456 (65.5) 761 (65.7) 
Lifestyle      
19 
 
Total PA (METs.h-1.week-1), mean 
(SD) 
73.1 (128.7) 104.8 
(131.4) 
143.5 
(154.3) 
189.6 
(146.4) 
Active commuting (min.day-1), mean 
(SD) 
0 (0) 17.5 (8.4) 49.4 (9.5) 167.8 
(116.4) 
Moderate PA (min.day-1), mean 
(SD) 
78.2 (142.9) 112.2 
(148.2) 
123.9 
(153.3) 
119.4 
(152.2) 
Vigorous PA (min.day-1), mean (SD) 39.2 (111.6) 47.4 (118.2) 67.1 (141.1) 59.5 (124.9) 
Sitting time  (h.day-1), mean (SD) 3.65 (2.5) 3.47 (2.9) 2.97 (2.3) 3.24 (2.5) 
Physical inactivity, n (%) 948 (52.8) 286 (19.5) 0 (0) 0 (0) 
Smoking, n (%) 
Never 
Ex-smoker 
Smoker 
 
783 (43.7) 
428 (23.9) 
582 (32.5) 
 
590 (40.6) 
351 (24.1) 
513 (35.3) 
 
313 (40.7) 
187 (24.3) 
270 (35.1) 
 
493 (39.1) 
302 (23.7) 
465 (36.9) 
Fruit and vegetable (g.day-1), mean 
(SD) 
213.5 
(138.6) 
214.4 
(136.1) 
210.9 
(132.9) 
219.9 
(142.1) 
Alcohol intake (g.day-1), mean (SD) 55.1 (110.2) 52.9 (88.4) 47.2 (50.5) 56.7 (89.2) 
Salt intake, (g.day-1), mean (SD) 9.75 (3.1) 9.82 (3.1) 9.73 (2.8) 9.67 (2.6) 
Metabolic and health outcomes     
Systolic Blood pressure (mmHg), 
mean (SD) 
129.4 (23.5) 127.1 (23.1) 126.7 (21.8) 125.6 (20.7) 
Diastolic Blood pressure (mmHg), 
mean (SD) 
76.1 (11.2) 75.8 (11.2) 75.9 (10.9) 76.1 (11.3) 
Glucose (mmol.l-1), mean (SD) 5.43 (1.8) 5.34 (1.8) 5.36 (1.7) 5.22 (1.4) 
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Total Cholesterol (mmol.l-1), mean 
(SD) 
5.08 (1.1) 5.03 (1.1) 5.01 (1.1) 4.97 (1.11) 
HDL-cholesterol (mmol.l-1), mean 
(SD) 
1.23 (0.3) 1.22 (0.3) 1.22 (0.3) 1.21 (0.3) 
Triglycerides (mmol.l-1), mean (SD) 1.71 (1.3) 1.69 (1.2) 1.58 (1.2) 1.70 (1.5) 
T2D, n (%) 230 (14.3) 142 (11.0) 75 (11.1) 91 (8.0) 
Metabolic Syndrome, n (%) 375 (42.4) 236 (33.1) 206 (32.8) 111 (29.9) 
Hypertension, n (%) 593 (35.5) 442 (32.4) 218 (30.6) 334 (28.8) 
SD: standard deviation, n: numbers, MET: metabolic equivalent task. Data is presented 447 
as mean and SD for continuous variables and number and % for categorical variables. 448 
Physical inactivity was defined as <600 METS.min.week-1 of moderate-equivalent 449 
physical activity.  450 
  451 
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 452 
FIGURE LEGENDS  453 
 454 
Figure 1 . Association of active commuting time with anthropometric and metabolic 455 
markers.  456 
Data is presented as delta and their 95% CI. Non-active commuters are used as reference 457 
group. Analyses were adjusted for age, sex, education, smoking, leisure PA, sitting time, 458 
fruit and vegetable, salt and alcohol intake. Metabolic markers were additionally adjusted 459 
for BMI.  460 
 461 
Figure 2. Association of active commuting with obesity, diabetes and metabolic 462 
syndrome.  463 
Data is presented as odds ratio and their 95% CI. Non-active commuters are used as 464 
reference group. Analyses were adjusted for age, sex, education, smoking, leisure PA, 465 
sitting time, fruit and vegetable, salt and alcohol intake. Analysis for T2D and metabolic 466 
syndrome were additionally adjusted for BMI.  467 
 468 
